Type-1 ribosome-inactivating protein
The invention relates to a novel ribosome-binding protein derived from Bougainvillea spectabilis having a molecular weight of about 26,000 daltons by polyacrylamide gel electrophoresis under reducing and non-reducing conditions, a pI of about 9.0, and a specified amino-terminal amino acid sequence. The invention further relates to a conjugate of the protein with a targeting ligand, such as an antibody, to form an immunotoxin. The protein and the conjugate are useful in therapy, for example, in the control of tumour cells or viruses.
1. An isolated B. spectabilis polynucleotide comprising SEQ ID NO: 8, wherein the polynucleotide encodes a polypeptide that has ribosome inactivation protein activity.
2. A recombinant vector comprising the polynucleotide according to claim l.
3. The recombinant vector of claim 2 , further comprising transcriptional and translational control sequences operably linked to the encoding polynucleotide.
4. A host cell transfected with the recombinant vector of claim 2 .
5. An isolated B. spectabilis polynucleotide encoding a polypeptide comprising SEQ ID NO: 9, wherein the encoded polypeptide has ribosome inactivating protein activity.
6. A recombinant vector comprising the polynucleotide according to claim 5 .
7. The recombinant vector of claim 6 , further comprising transcriptional and translational control sequences operably linked to the encoding polynucleotide.
8. A host cell transfected with the recombinant vector of claim 6 .